![(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJCC78409.webp&w=3840&q=75)

(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide
CAS:
Ref. 3D-JCC78409
5mg
1.453,00€
10mg
2.265,00€
25mg
4.246,00€
50mg
6.794,00€
![(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJCC78409.webp&w=3840&q=75)

Información del producto
Nombre:(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide
Marca:Biosynth
Descripción:(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide (PDE10A) is a potential drug target for various inflammatory diseases such as reactive arthritis and autoimmune diseases. It is a hydrophilic molecule that functions by binding to the enzyme cyclic guanosine monophosphate (cGMP) phosphodiesterase 10A (PDE10A). PDE10A hydrolyzes cGMP to GMP. This inhibitor blocks the production of cAMP and therefore reduces inflammation and pain. PDE10A also has anti-proliferative effects on certain cancer cells in vitro.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:435.6 g/mol
Fórmula:C25H33N5O2
Pureza:Min. 95%
Consulta técnica sobre: (αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.